Key role of effector memory CD4+ T lymphocytes in a short- incubation heparin-binding hemagglutinin gamma interferon release assay for the detection of latent tuberculosis

Clinical and Vaccine Immunology

Volumn 21, Issue 3, 2014, Pages 321-328

  Wyndham Thomas, Chloé ^a   Corbière, Véronique ^a   Dirix, Violette ^a   Smits, Kaatje ^a   Domont, Fanny ^a,f   Libin, Myriam ^a   Loyens, Marc ^b,c,d   Locht, Camille ^b,c,d   Mascart, Françoise ^a,e  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b INSERM U1019   (France)

^c UNIV LILLE   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

^e ERASME HOSPITAL   (Belgium)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HEMAGGLUTININ; HEPARIN; INTERLEUKIN 7;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; HUMAN; IMMUNOCOMPETENCE; INCUBATION TIME; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROCESS OPTIMIZATION;

ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CULTURE MEDIA; FEMALE; HUMANS; INTERFERON-GAMMA RELEASE TESTS; INTERLEUKIN-7; LATENT TUBERCULOSIS; LECTINS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TIME FACTORS; YOUNG ADULT;

EID: 84896777518     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00651-13     Document Type: Article

References (24)

1. Huebner RE, Schein MF, Bass JB, Jr. 1993. The tuberculin skin test. Clin. Infect. Dis. 17:968-975. http://dx.doi.org/10.1093/clinids/17.6.968. (Pubitemid 23358739)
2. Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, Bossink A, Magdorf K, Hölscher C, Kampmann B, Arend SM, Detjen A, Bothamley G, Zellweger JP, Milburn H, Diel R, Ravn P, Cobelens F, Cardona PJ, Kan B, Solovic I, Duarte R, Cirillo DM, Lange C, TBNET. 2009. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur. Respir. J. 33:956-973. http://dx.doi.org/10.1183/09031936. 00120908.
3. Butera O, Chiacchio T, Carrara S, Casetti R, Vanini V, Meraviglia S, Guggino G, Dieli F, Vecchi M, Lauria FN, Marruchella A, Laurenti P, Singh M, Caccamo N, Girardi E, Goletti D. 2009. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response. BMC Infect. Dis. 9:182. http://dx.doi.org/10.1186/1471-2334-9-182.
4. Leyten EM, Arend SM, Prins C, Cobelens FG, Ottenhoff TH, van Dissel JT. 2007. Discrepancy between Mycobacterium tuberculosis -specific gamma interferon release assays using short and prolonged in vitro incubation. Clin. Vaccine Immunol. 14:880-885. http://dx.doi.org/10.1128/CVI.00132-07.
5. Hougardy JM, Schepers K, Place S, Drowart A, Lechevin V, Verscheure V, Debrie AS, Doherty TM, Van Vooren JP, Locht C, Mascart F. 2007. Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis. PLoS One 2:e926. http://dx.doi.org/10.1371/journal.pone. 0000926.
6. Locht C, Hougardy JM, Rouanet C, Place S, Mascart F. 2006. Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis. Tuberculosis (Edinb.) 86: 303-309. http://dx.doi.org/10.1016/j.tube.2006.01.016.
7. Corbière V, Pottier G, Bonkain F, Schepers K, Verscheure V, Lecher S, Doherty TM, Locht C, Mascart F. 2012. Risk stratification of latent tuberculosis defined by combined interferon gamma release assays. PLoS One 7:e43285. http://dx.doi.org/10.1371/journal.pone.0043285.
8. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. 2010. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Morb. Mortal. Wkly. Rep. 59:1-25.
9. Place S, Verscheure V, de San N, Hougardy JM, Schepers K, Dirix V, Dediste A, Michel O, Drowart A, Allard SD, Doherty TM, Lecher S, Locht C, Mascart F. 2010. Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humans. Am. J. Respir. Crit. Care Med. 182:848-854. http://dx.doi.org/10.1164/rccm.201001-0083OC.
10. Masungi C, Temmerman S, Van Vooren JP, Drowart A, Pethe K, Menozzi FD, Locht C, Mascart F. 2002. Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis. J. Infect. Dis. 185:513-520. http://dx.doi.org/10.1086/338833. (Pubitemid 34142814)
11. Delogu G, Chiacchio T, Vanini V, Butera O, Cuzzi G, Bua A, Molicotti P, Zanetti S, Lauria FN, Grisetti S, Magnavita N, Fadda G, Girardi E, Goletti D. 2011. Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders. PLoS One 6:e18315. http://dx.doi.org/10.1371/journal.pone.0018315.
12. Feske M, Nudelman RJ, Medina M, Lew J, Singh M, Couturier J, Graviss EA, Lewis DE. 2008. Enhancement of human antigen-specific memory T-cell responses by interleukin-7 may improve accuracy in diagnosing tuberculosis. Clin. Vaccine Immunol. 15:1616-1622. http://dx.doi.org/10.1128/CVI.00185-08.
13. Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, Almeida JR, Gostick E, Yu Z, Carpenito C, Wang E, Douek DC, Price DA, June CH, Marincola FM, Roederer M, Restifo NP. 2011. A human memory T cell subset with stem cell-like properties. Nat. Med. 17:1290-1297. http://dx.doi.org/10.1038/nm.2446.
14. Rathmell JC, Farkash EA, Gao W, Thompson CB. 2001. IL-7 enhances the survival and maintains the size of naive T cells. J. Immunol. 167:6869-6876. (Pubitemid 33144179)
15. Borger P, Kauffman HF, Postma DS, Vellenga E. 1996. IL-7 differentially modulates the expression of IFN-gamma and IL-4 in activated human T lymphocytes by transcriptional and post-transcriptional mechanisms. J. Immunol. 156:1333-1338. (Pubitemid 26065839)
16. Fondation contre les Affections Respiratoires et pour l'Education a la Sante. 2003. Recommandations concernant le dépistage ciblé et le traitement de l'infection tuberculeuse latente. FARES, Brussels, Belgium. http://www.fares.be/documents/recomm.pdf.
17. Farhat M, Greenaway C, Pai M, Menzies D. 2006. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int. J. Tuberc. Lung Dis. 10:1192-1204. (Pubitemid 44713473)
18. Young DB, Gideon HP, Wilkinson RJ. 2009. Eliminating latent tuberculosis. Trends Microbiol. 17:183-188. http://dx.doi.org/10.1016/j.tim.2009.02.005.
19. Delogu G, Fadda G, Brennan MJ. 2012. Impact of structural domains of the heparin binding hemagglutinin of Mycobacterium tuberculosis on function. Protein Pept. Lett. 19:1035-1039. http://dx.doi.org/10.2174/092986612802762697.
20. Temmerman ST, Place S, Debrie AS, Locht C, Mascart F. 2005. Effector functions of heparin-binding hemagglutinin-specific CD8+ T lymphocytes in latent human tuberculosis. J. Infect. Dis. 192:226-232. http://dx.doi.org/10.1086/ 430930. (Pubitemid 40993392)
21. Godkin AJ, Thomas HC, Openshaw PJ. 2002. Evolution of epitopespecific memory CD4+ T cells after clearance of hepatitis C virus. J. Immunol. 169:2210-2214. (Pubitemid 34857690)
22. Nelson RW, McLachlan JB, Kurtz JR, Jenkins MK. 2013. CD4+ T cell persistence and function after infection are maintained by low-level peptide: MHC class II presentation. J. Immunol. 190:2828-2834. http://dx.doi.org/10.4049/ jimmunol.1202183.
23. Stephens R, Langhorne J. 2010. Effector memory Th1 CD4 T cells are maintained in a mouse model of chronic malaria. PLoS Pathog. 6:e1001208. http://dx.doi.org/10.1371/journal.ppat.1001208.
24. Goletti D, Butera O, Bizzoni F, Casetti R, Girardi E, Poccia F. 2006. Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis. J. Infect. Dis. 194:984-992. http://dx.doi.org/10.1086/507427. (Pubitemid 44454084)